PubRank

Joerg Petersen

Author PubWeight™ 19.87‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism. Hepatology 2014 2.39
2 Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology 2006 2.05
3 Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis. Gut 2012 1.86
4 IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J Clin Invest 2012 1.81
5 Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients. Gastroenterology 2007 1.75
6 Virion half-life in chronic hepatitis B infection is strongly correlated with levels of viremia. Hepatology 2008 1.68
7 Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice. Gastroenterology 2011 1.17
8 Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes. J Hepatol 2005 1.09
9 Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP-ribosyl)ation. Hepatology 2002 1.07
10 Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection. Dig Dis Sci 2014 1.02
11 In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice. Hepatology 2010 0.93
12 The replication cycle of hepatitis B virus. J Hepatol 2009 0.91
13 Morphological and functional analysis of rat hepatocyte spheroids generated on poly(L-lactic acid) polymer in a pulsatile flow bioreactor. Tissue Eng 2006 0.90
14 Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication. Antivir Ther 2008 0.87
15 Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID mice. Antivir Ther 2012 0.75
16 Latest developments in the treatment of hepatitis B. Minerva Gastroenterol Dietol 2015 0.75